PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Additional Block Listing of Ordinary Shares

7 Aug 2020 12:52

RNS Number : 5348V
Cello Health PLC
07 August 2020
 

7 August 2020

Cello Health plc

("Cello" or the "Company")

Additional Block Listing of Ordinary Shares

 

Following the Court Hearing held earlier today in connection with the cash acquisition of Cello Health plc by Pharma Value Demonstration Bidco Limited, the Company announces that an application has been made for a block admission for 2,421,000 new ordinary shares of 10p each ("Ordinary Shares") to be admitted to trading on AIM.

 

These new Ordinary Shares will be issued and allotted pursuant to the exercise of existing options under the Company's Performance Share Plan 2010, the HM Revenue & Customs Approved Company Share Option Plan and its Unapproved Share Option Plan. New Ordinary Shares, when issued, will rank pari passu with the existing Ordinary Shares of the Company.

 

Admission of the new Ordinary Shares is expected to occur on 10 August 2020.

 

 

Enquires

Cello Health

020 7812 8460

Mark Scott, Chief Executive

Mark Bentley, Group Finance Director

Cenkos Securities

020 7397 8900

Giles Balleny

Harry Hargreaves

Buchanan

020 7466 5000

Mark Court

Jamie Hooper

Sophie Wills

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ALSEAFPXELNEEFA

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.